A. Wesley Burks MD

Allergy & Immunology•Chapel Hill, NC

Pediatric Asthma & Allergic Conditions

Dean, UNC School of Medicine CEO UNC Health Care System Vice-Chancellor for Medical Affairs, UNC

Join to View Full Profile

4032 Bondurant HL CB 7000Chapel Hill, NC 27599
Phone+1 919-966-4161

Education & Training

Duke University HospitalFellowship, Allergy and Immunology, 1983 - 1985
University of Arkansas for Medical Sciences (UAMS) College of MedicineResidency, Pediatrics, 1980 - 1983
University of Arkansas For Medical Sciences College of MedicineClass of 1980

Certifications & Licensure

NC State Medical License 1983 - 2026
AR State Medical License 1980 - 2025
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics

Clinical Trials

Immunotherapy for Peanut Allergy Start of enrollment: 2006 Apr 01
Completed
Not Applicable
Oral Immunotherapy for Childhood Egg Allergy Start of enrollment: 2007 May 01
Completed
Phase 2
A Randomized, Double-Blind Placebo-Controlled Peanut Sublingual Immunotherapy Trial Start of enrollment: 2007 Dec 01
Completed
Phase 1, Phase 2
Treatment of Egg Allergy in Children Through Oral Desensitization (EGG OIT) Start of enrollment: 2003 Feb 01
Completed
Not Applicable
Oral Immunotherapy for Peanut Allergy (PMIT) Start of enrollment: 2007 Mar 01
Completed
Phase 2
A Study of Sublingual Immunotherapy in Peanut-allergic Children Start of enrollment: 2008 Jan 01
Completed
Phase 2
Oral Peanut Immunotherapy for Peanut Allergic Patients Start of enrollment: 2003 Mar 01
Oral Immunotherapy (OIT) for Peanut Allergy Start of enrollment: 2009 Apr 01
Completed
Phase 2
Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy Start of enrollment: 2009 Jul 01
Completed
Phase 1, Phase 2
Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL Study Start of enrollment: 2009 Jun 22
Completed
Phase 2
Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in Adults Start of enrollment: 2010 Dec 01
Terminated
Phase 1, Phase 2
Eosinophilic Esophagitis Databank Start of enrollment: 2011 Apr 01
Completed
Sublingual Immunotherapy for Peanut Allergy and Induction of Tolerance Start of enrollment: 2011 Jun 01
Completed
Phase 1, Phase 2
Mechanisms of Desensitization During Peanut Oral Immunotherapy Start of enrollment: 2013 Apr 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

16 citations
Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut-allergic children.
Edwin H Kim, Corinne A Keet, Yamini V Virkud, Stacy Chin, Ping Ye
The Journal of Allergy and Clinical Immunology. 2023-06-01
16 citations
Allergen recognition by specific effector Th2 cells enables IL-2-dependent activation of regulatory T-cell responses in humans.
Daniel Lozano-Ojalvo, Scott R Tyler, Carlos J Aranda, Julie Wang, Scott Sicherer
Allergy. 2023-03-01
Intestinal epithelial cell barrier dysfunction and elevated Angiopoietin-like 4 identified in orally susceptible peanut allergy model.
Erin C Steinbach, Johanna M Smeekens, Satyaki Roy, Takahiko Toyonaga, Caleb Cornaby
Clinical and Experimental Allergy. 2023-02-01

Other

Clinical manifestations of food allergy: An overview
Burks W
http://www.uptodate.com/contents/clinical-manifestations-of-food-allergy-an-overview
UpToDate, Wolters Kluwer Health - 2012-06-05
Diagnostic evaluation of food allergy
Burks W
http://www.uptodate.com/contents/diagnostic-evaluation-of-food-allergy
UpToDate, Wolters Kluwer Health - 2012-03-27
History and physical examination in the patient with possible food allergy
Burks W
http://www.uptodate.com/contents/history-and-physical-examination-in-the-patient-with-possible-food-
UpToDate, Wolters Kluwer Health - 2012-06-05

Grant Support

Sublingual Immunotherapy For Peanut AllergyNational Center For Complementary &Alternative Medicine2008–2012
Combined Peanut Oral Immunotherapy And Anti-Ige: Mechanistic StudiesNational Institute Of Allergy And Infectious Diseases2011
Understanding The Mechanism Of Mucosal ImmunotherapyNational Institute Of Allergy And Infectious Diseases2007–2011
Research Training In Allergy And Clinical ImmunologyNational Institute Of Allergy And Infectious Diseases2006–2011
Immunotherapy For Peanut AllergyNational Center For Complementary &Alternative Medicine2005–2007
Treatment Of EGG Allergy In Children Through Oral DesensitizationNational Center For Research Resources2005
Oral Peanut Immunotherapy For Peanut Allergic PatientsNational Center For Research Resources2005
Soy Immunotherapy For Patients With Peanut AnaphylaxisNational Institute Of Allergy And Infectious Diseases2004
EGG Allergy In Children Through Oral DesensitizationNational Center For Research Resources2004
Immunotherapy For Patients With Peanut AnaphylaxisNational Institute Of Allergy And Infectious Diseases2003
Immunotherapy For Patients With Peanut AnaphylaxisNational Institute Of Allergy And Infectious Diseases2002
Arkansas Children Hosp RES Inst Constr: Pain OsteogenesisNational Center For Research Resources2002
Arkansas Children Hosp RES Inst Constr: Neonatal Birth DefectNational Center For Research Resources2002
Extramural RES Facilities Constr ProjNational Center For Research Resources2001–2002
Immunotherapy For Patients With Peanut AnaphylaxisNational Institute Of Allergy And Infectious Diseases1999–2001
Molecular And Immunologic Studies Of Peanut AllergensNational Institute Of Allergy And Infectious Diseases1995–1997
Allergenicity Of Major Component Proteins Of SoybeanNational Institute Of Allergy And Infectious Diseases1989–1993

A. Wesley Burks MD

Dr. Burks is on Doximity

Education & Training

Certifications & Licensure

Clinical Trials

Publications & Presentations

Grant Support

Viewing the full profile is available to verified healthcare professionals only.